Shizhen Pavilion Store People's Livelihood Pharmacy Service Station Put into Operation
Release time:
2021-07-21
News from our newspaper 6# February 21 , Jianfeng Pharmacy and Wucheng District Market Supervision Bureau signed an agreement on the construction of Minsheng Pharmacy Service Station. Shizhen Pavilion Pharmacy Minsheng Pharmacy Service Station was inaugurated and officially became one of Jinhua 8 pharmacies with Minsheng Pharmacy Service Station, providing convenient and efficient medication guidance, processing of Chinese herbal pieces, personal drug use files and other public welfare services at home.
People's Livelihood Pharmacy Service Station Construction is one of the "Top Ten People's Livelihood Facts " established in Zhejiang Province 2021 . It is to select a batch of chain stores with standardized quality management, good credit rating, and high awareness of social responsibility and law-abiding operation from existing retail pharmacies, and set up People's Livelihood Pharmacy Service Station in their business premises, let the people at home will be able to enjoy a full range of pharmaceutical services. People's livelihood pharmaceutical service stations are divided into three-star, four-star and five-star 3 grades, of which the three-star standard is the basic standard. All people's livelihood pharmaceutical service stations should meet the relevant conditions, while the five-star service stations should have a special service area of more than 65 square meters, provide more than 17 pharmaceutical services including medication guidance, customer medication follow-up, traditional Chinese medicine powder, and personal medical device calibration agency. After
was selected as a designated pharmacy for chronic diseases in 2014 , the store set up a chronic disease health care center in cooperation with manufacturers to better serve chronic disease patients. for many years, it has been providing chronic disease health services such as blood sugar and blood pressure measurement for the common people, forming a good reputation. Now, in response to the government's call on the original basis, it has been upgraded to a people's livelihood pharmaceutical service station with higher service standards. When applying independently, the highest five-star standard was chosen. In addition to the required 17 necessary service items, the Minsheng Pharmaceutical Service Station of Shizhen Pavilion Store also has 6 items such as chronic disease files, drug search for customers, and drug delivery. Since the construction was completed on 2021 1 1 , more than 9000 customers in need of help have been received. Chen Jing, manager of
, said that the competition in the pharmaceutical retail industry is fierce, the state has strengthened the supervision of the pharmaceutical industry, centralized procurement and other policies have generally reduced the price of drugs, and the diversion of customers from community and township health centers has brought great operating pressure to retail pharmacies. We can only continuously improve the quality of service and make the service more detailed to increase the stickiness of customers to us, to make us in an invincible position in the competition. For this reason, we take the opportunity of building a people's livelihood pharmaceutical service station to reorganize the service items and improve the service quality under the supervision of the government. At the same time, the popularity of the store can also be improved, which can help more citizens. (Reporter Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page